Stockholm, June 23, 2011 – NASDAQ OMX (NASDAQ:NDAQ) announces that Boule Diagnostics AB (BOUL), a small cap company within the healthcare sector, today starts trading of its shares on the main market of NASDAQ OMX Stockholm.
Boule Diagnostics AB is an international group of companies with subsidiaries in Sweden, the US and China. Since its inception in 1992, Boule Diagnostics has rapidly grown into an international diagnostics company that develops, manufactures and sells complete solutions with both instruments and consumables for blood diagnostics.
Ernst Westman, CEO of Boule Diagnostics AB, commented: “We are an international company with high and profitable growth. We are investing to open up new markets and continue to grow. A listing on NASDAQ OMX is a logical step for us to ensure that we will be able to source capital to facilitate our development. We are a company with strong international competitiveness, which should interest both institutional and private investors.”
Jenny Rosberg, Senior Vice President at NASDAQ OMX said: “We are pleased to welcome Boule Diagnostics to NASDAQ OMX main market, where they will make a valuable addition to our healthcare sector. Boule Diagnostics is yet another venture capital backed company to join NASDAQ OMX and we are looking forward to providing the company with the liquidity and investor reach advantages that come with the main market listing”.
- # -
About NASDAQ OMX
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with approximately 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook (http://www.facebook.com/nasdaqomx) and Twitter (http://www.twitter.com/nasdaqomx).
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
- # -
Media contacts:
Martin Hedensiö
+46 8 405 62 54
martin.hedensio@nasdaqomx.com